Skip to main content
Year archive

ANATARA LIFESCIENCES LTD — 2023 filings

All 60 regulatory filings released by ANATARA LIFESCIENCES LTD (ANR) in 2023, sourced directly from the official regulator.

60 Filings
2023 Period
2023 filings (60)
Filing Released Lang
Anatara finalises Entitlement Issue 2 pages 140.4KB
Capital/Financing Update
2023-12-17 English
Application for quotation of securities - ANR 6 pages 27.6KB
Share Issue/Capital Change
2023-12-17 English
Cleansing Notice 2 pages 184.7KB
Capital/Financing Update
2023-12-17 English
Change of Director's Interest Notice 3 pages 237.1KB
Director's Dealing
2023-12-12 English
Change of Director's Interest Notice 3 pages 231.8KB
Director's Dealing
2023-12-11 English
Change of Director's Interest Notice 3 pages 232.4KB
Director's Dealing
2023-12-10 English
Change of Director's Interest Notice 3 pages 237.3KB
Director's Dealing
2023-12-10 English
Application for quotation of securities - ANR 6 pages 27.8KB
Share Issue/Capital Change
2023-12-10 English
Cleansing Notice 2 pages 186.4KB
Capital/Financing Update
2023-12-10 English
Application for quotation of securities - ANR 6 pages 28.0KB
Share Issue/Capital Change
2023-12-07 English
Entitlement Offer Results 3 pages 213.1KB
Capital/Financing Update
2023-12-06 English
Notification of cessation of securities - ANR 4 pages 23.9KB
Regulatory Filings
2023-12-03 English
Entitlement offer opens and dispatch of Offer Booklet 3 pages 199.2KB
Capital/Financing Update
2023-11-12 English
Non-Renounceable Entitlement Offer Booklet 43 pages 636.5KB
Capital/Financing Update
2023-11-12 English
Letter to Eligible Shareholders 3 pages 157.4KB
Capital/Financing Update
2023-11-12 English
Letter to Ineligible Shareholders 3 pages 155.6KB
Capital/Financing Update
2023-11-12 English
Notification of cessation of securities - ANR 4 pages 24.0KB
Share Issue/Capital Change
2023-11-09 English
AGM Chair Address 2 pages 169.8KB
AGM Information
2023-11-09 English
GaRP Clinical Trial AGM Presentation 14 pages 1.3MB
Investor Presentation
2023-11-09 English
Results of Meeting 2 pages 375.8KB
Declaration of Voting Results & Voting Rights Announcements
2023-11-09 English
Cleansing Notice 5 pages 239.0KB
Capital/Financing Update
2023-11-05 English
Anatara launches a partially underwritten Entitlement Offer 8 pages 309.8KB
Capital/Financing Update
2023-11-02 English
Cleansing Notice 4 pages 186.7KB
Capital/Financing Update
2023-11-02 English
Proposed issue of securities - ANR 7 pages 34.2KB
Capital/Financing Update
2023-11-02 English
Letter to Optionholders 2 pages 134.3KB
Capital/Financing Update
2023-11-02 English
Trading Halt 2 pages 233.9KB
Capital/Financing Update
2023-10-31 English
Appendix 4C & Q1 FY24 Activities Report 15 pages 681.6KB
Interim / Quarterly Report Q1 2024
2023-10-30 English
Webinar Investor Presentation 30 pages 4.9MB
Investor Presentation
2023-10-18 English
Anatara IBS trial positive secondary endpoint data analysis 10 pages 510.2KB
Capital/Financing Update
2023-10-16 English
IBS Trial Results Webinar and QA 2 pages 226.7KB
Regulatory Filings
2023-10-16 English
Trading Halt 2 pages 553.2KB
Regulatory Filings
2023-10-15 English
Annual Report to shareholders 73 pages 2.0MB
Regulatory Filings
2023-10-15 English
Appendix 4G and Corporate Governance Statement 26 pages 614.2KB
Governance Information
2023-10-15 English
Notice of Annual General Meeting/Proxy Form 30 pages 460.7KB
AGM Information
2023-10-08 English
Anatara Board Changes 2 pages 215.1KB
Board/Management Information
2023-10-01 English
Initial Director's Interest Notice 2 pages 159.4KB
Director's Dealing
2023-10-01 English
Final Director's Interest Notice 2 pages 200.7KB
Director's Dealing
2023-10-01 English
ANR announces Positive Results from Stage 1 of IBS trial 7 pages 405.6KB
Regulatory Filings
2023-09-27 English
Pause in Trading 1 page 118.7KB
Regulatory Filings
2023-09-25 English
Trading Halt 2 pages 550.1KB
Regulatory Filings
2023-09-25 English
Anatara Annual General Meeting & Director Nominations 1
AGM Information
2023-09-18 English
IBS clinical trial Stage 1 patients finalised 4 pages 354.6KB
Regulatory Filings
2023-08-30 English
Appendix 4E & Audited Financial Statements 30 June 2023 60 pages 872.4KB
Annual Report FY 2023
2023-08-23 English
$923,235 in R&D tax incentive received 2 pages 188.0KB
Capital/Financing Update
2023-08-13 English
Notification regarding unquoted securities - ANR 6 pages 28.3KB
Share Issue/Capital Change
2023-07-31 English
Appendix 4C & Q4 FY23 Activities Report 8 pages 514.6KB
Interim / Quarterly Report Q4 2023
2023-07-30 English
Anatara Update on GaRP Irritable Bowel Syndrome Trial 3 pages 342.7KB
Regulatory Filings
2023-06-05 English
Anatara Investor Presentation 20 pages 2.8MB
Investor Presentation
2023-05-07 English
Appendix 4C & Q3 FY23 Activities Report 8 pages 486.9KB
Interim / Quarterly Report Q3 2023
2023-04-19 English
Registered Office Change 1 page 146.4KB
Regulatory Filings
2023-04-19 English
Change in substantial holding 2 pages 1.7MB
Regulatory Filings
2023-03-27 English
Anatara Company Update 3 pages 280.4KB
Capital/Financing Update
2023-03-09 English
Half Yearly Report and Accounts 21 pages 357.8KB
Interim / Quarterly Report H1 2023
2023-02-23 English
Placement of Shortfall from Entitlement Offer 2 pages 170.7KB
Capital/Financing Update
2023-02-20 English
Application for quotation of securities - ANR 6 pages 27.9KB
Capital/Financing Update
2023-02-20 English
Notification regarding unquoted securities - ANR 5 pages 26.5KB
Share Issue/Capital Change
2023-02-20 English
Application for quotation of securities - ANR 6 pages 27.9KB
Share Issue/Capital Change
2023-01-29 English
Notification of cessation of securities - ANR 4 pages 24.4KB
Share Issue/Capital Change
2023-01-18 English
Revised Appendix 4C 6 pages 375.0KB
Interim / Quarterly Report Q2 2023
2023-01-12 English
Appendix 4C & Q2 FY23 Activities Report 8 pages 486.2KB
Interim / Quarterly Report Q2 2023
2023-01-11 English